Primary aldosteronism is characterized by autonomous aldosterone production leading to suppression of renin. Hence, an elevated ratio is pathognomonic if confirmed.
| Aldosterone Units | Renin Assay | Cutoff for Positive Screen |
|---|---|---|
| ng/dL (conventional) | Plasma Renin Activity (PRA, ng/mL/h) | > 20 - 30 (with PAC > 15) |
| ng/dL | Direct Renin Concentration (DRC, mU/L) | > 2.4 - 3.8 (with PAC > 15) |
| pmol/L (SI units) | PRA (ng/mL/h) | > 550 - 830 (with PAC > 416) |
| pmol/L | DRC (mU/L) | > 66 - 105 (with PAC > 416) |
False positives: Beta-blockers, central alpha-2 agonists, NSAIDs (suppress renin). False negatives: Diuretics, ACE inhibitors, ARBs, MRAs (increase renin). Spironolactone/eplerenone must be withdrawn for at least 4 weeks before testing.
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment